The Battle against “Silent” Liver Disease
Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.
Read MorePosted by Laurie Bonner | Mar 26, 2021 | Disease States |
Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.
Read MorePosted by Melanie Hamilton-Basich | Mar 24, 2021 | Company News |
The OGT brand refresh has been driven by a desire to fully integrate the company’s three well-known brands of genomics solutions—CytoCell FISH probes, CytoSure array and NGS products, and SureSeq NGS panels.
Read MorePosted by Laurie Bonner | Mar 19, 2021 | Diabetes & Metabolic Diseases, POC Instruments |
EKF Diagnostics’ Stat-Site WB measures whole blood β-ketone and glucose levels in seconds.
Read MorePosted by Laurie Bonner | Mar 17, 2021 | Covid 19, Hematology & Serology |
The templates offer recommendations on what to include in emergency use authorization requests or pre-EUA submissions for serology tests.
Read MorePosted by Laurie Bonner | Mar 17, 2021 | Covid 19 |
HHS will invest $10 billion to ramp up screening testing to help schools reopen and $2.25 billion to scale up testing in underserved populations, and provide new guidance on asymptomatic screening testing in schools, workplaces, and congregate settings.
Read More